CRP | Fg | ESR | LDH | AST | ALT | Creatinine | Urea |
---|---|---|---|---|---|---|---|
41.66 mg/l | 497 mg/dl | 93 mm/h | 601 U/l | 21 U/l | 8 U/l | 0,69 mg/dl | 26,1 mg/dl |
CD34 | HLA-DR | CD13 | CD33 | CD15 | CD117 | CD19 | CD3 | CD7 | CD10 | CD22 | CD11 | CD14 | CD64 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
80% | 80% | 78% | 75% | 70% | 60% | 62% | negative | negative | negative | negative | negative | negative | negative |
Drug name | Strength | Dosage | Route of administration | Dates of administration |
---|---|---|---|---|
human immune globulin | 2,5g/25ml | 1 fl/day | intravenously | Day 13 |
(CSL Behring GmbH, Marburg, Germany) | ||||
red blood cell | 10ml/kg | intravenously | Day 9,21 | |
pooled platelets | 1unit/10kg | intravenously | Day 7-16, 21-25 | |
trimethoprim-sulfamethoxazole | (40mg/200mg)/5ml | 2x10ml/day | orally | Day 24-26 |
(E.I.P.I.Co., Tenth of Ramadan City, Egypt) | ||||
fluconazole | 2mg/ml | 100 mg once | intravenously | Day 17-27 |
(Fareva Amboise, Pocé-Sur-Cisse, France) | daily | |||
granisetron | 1mg/ml | 1mg twice a | Intravenously | Day 4-11 |
(Fresenius Kabi Austria GmbH, Graz, Austria) | day |